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ABSTRACT
In order to elucidate the possible genetic determinants of resistance to florfenicol and chloramphenicol in porcine Escherichia
coli in Taiwan, 600 fecal samples of healthy pigs from 50 different farms were collected from 2003 to 2007. The florfenicol resistance in the isolated E. coli strains doubled from 39.2% in 2003 to 78.3% in 2007. A total of 351 florfenicol-resistant E. coli isolates
were isolated from nursery pigs (61.5%), grower-finisher pigs (62.5%), and sows (51.5%). The prevalence of resistance genes, floR,
cmlA, cat-1, cat-2 and cat-3, was 82.9, 61.3, 10.8, 3.7, and 0%, respectively. Of the 351 florfenicol-resistant isolates, 184 (52.4%) were
positive for both floR and cmlA. Furthermore, the results of efflux inhibitor studies with Phe-Arg-β-naphthylamide showed a 4- to
64-fold decrease in the florfenicol MIC levels. The FloR efflux pump may play a role in phenicol resistance among porcine E. coli
isolates in Taiwan. More detailed studies are required to focus on the public health concerns about the spread of antimicrobial resistance from animal food products to humans through the food chain.
Key words: florfenicol, chloramphenicol, Escherichia coli, resistance, efflux pump

INTRODUCTION
Chloramphenicol is a broad-spectrum antibiotic
that was used extensively in veterinary medicine until
concerns over its toxicity emerged(1). Resistance to chloramphenicol may be mediated enzymatically through
the chemical inactivation of the drug. Different types of
chloramphenicol acetyltransferases (CATs) are responsible for most enzymatic resistance to chloramphenicol(24)
. CATs are only able to inactivate chloramphenicol and
thiamphenicol(2,3). Because of the existing adverse effects
and a high prevalence of resistance to chloramphenicol,
the newly developed fluorinated derivative of chloramphenicol, florfenicol, has been used as an alternative agent
for the control of bacterial respiratory tract infections in
cattle, pigs, poultry, and other animal species(5-10). After
florfenicol replaced chloramphenicol in most countries,
* Author for correspondence. Tel: +886-2-33663864;
Fax: + 886-2-23661475; E-mail: changsk@ntu.edu.tw

the prevalence of florfenicol resistance in E. coli and other
bacteria from animals has increased significantly in the
past decade (6,11-17). Active efflux pumps (cmlA and floR)
are important for intrinsic and acquired antibiotic resistance. Over-expression of efflux pumps affecting florfenicol or chloramphenicol is becoming increasingly common
in E. coli(6,17,18). The floR gene confers resistance to both
chloramphenicol and florfenicol, but the cmlA gene only
mediates resistance to chloramphenicol(15,17-20). These
two genes are located either in the chromosomal DNA or
on plasmids in E. coli(6,12,13,21). Recently, organization of
the floR gene on plasmid pMBSF1 in porcine E. coli has
been reported by Blickwede and Schwarz (6). By comparing the locations, the detailed sequences and the pulsed
field gel electrophoresis (PFGE) patterns with other
bacterial species or E. coli isolates(6,14,16,17,21,22), the presence of a mobile floR-carrying element, a putative new
integron, was identified(6). Efflux pump inhibitors have
been investigated with a view to improving and potentiat-
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ing the activity of exported antibiotics. Phe-Arg-β-naphthylamide (PAβN) has been described as a broad-spectrum efflux pump inhibitor in E. coli(23). In this study, the
effects of PAβN on the active efflux systems were tested
for possible additive effects on resistance to phenicols.
Currently, very little information is available regarding the prevalence of phenicol-resistant E. coli in domestic animals, particularly in healthy pigs. The aim of this
study was thus to determine the prevalence of resistance
to florfenicol and chloramphenicol, and of efflux pump
systems present in porcine E. coli isolates.

MATERIALS AND METHODS
I. Bacterial Isolation and Culture Conditions
We evaluated fecal samples from 50 swine farms in
Taiwan from 2003 to 2007. At each farm, 12 fecal samples
were collected directly from the rectum of the individual
animal. The rectal samples from pigs were collected in
three different production stages in each farm: nursery
pigs (n = 4), grower-finisher pigs (n = 4), and sows (n = 4).
The sampling number for different stages was based on
the average total number of pigs in each farm. Each year,
120 samples (from 10 pig farms) were collected. A total
of 600 samples were obtained from 50 different farms.
Fecal samples were collected directly from the rectums
of the animals using aseptic cotton swabs and buffered
peptone water (Becton Dickinson Microbiology Systems,
Cockeysville, MD, USA). After overnight incubation at
35°C, the broth was inoculated onto MacConkey agar
plates (Becton Dickinson) containing 8 mg/L of florfenicol (Sigma Aldrich, St Louis, MO, USA). For individual
rectum sample, two colonies with typical E. coli morphologic characters were selected at random and subjected
to standard biochemical tests (gram stain, oxidase, triple
sugar iron (TSI), indole production, citrate fermentation,
methyl red, ornithine decarboxylase fermentation, and
urea agar) for identification(24). Furthermore, all E. coli
isolates were confirmed biochemically by using the API
20E system (BioMérieux, Marcy-l’Étoile, France). If the
two colonies had the same results, only one of the colonies was used for further analysis.
II. Antimicrobial Susceptibility Testing
The minimal inhibitory concentrations (MICs) for
florfenicol-resistant E. coli strains were determined in
Mueller-Hinton agar by the standard twofold dilution
method in accordance with the guidelines of the CLSI
(Clinical and Laboratory Standards Institute; formerly
NCCLs)(25). Eleven antimicrobial agents were tested.
Ampicillin, chloramphenicol, colistin, florfenicol, gentamicin, nalidixic acid, and oxytetracycline were purchased
from Sigma, enrofloxacin and ciprofloxacin from Fluka
Chemie (Buchs, Switzerland), amoxicillin-clavulanic acid

from GlaxoSmithKline Biologicals (Stevenage, UK), and
ceftiofur (Excenel RTU) from Pfizer Animal Health (Karlsruhe, Germany). The solvents and diluents used for stock
and standard solutions followed the CLSI guidelines(25).
The antimicrobial agents to be tested were selected
according to the following criteria: substances commonly
used in pig farms (all listed antimicrobial agents, except
for amoxicillin-clavulanic acid, ciprofloxacin, and chloramphenicol), substances used exclusively for veterinary
clinical therapy (florfenicol, ceftiofur, and enrofloxacin),
substances used exclusively for human medicine (ciprofloxacin), and substances used for both human and veterinary medical purposes (ampicillin, and colistin). Based on
their spectra of activity and clinical usage, these agents
may induce different levels of resistance in bacteria. Reference strains of E. coli ATCC 25922, Enterococcus faecalis ATCC 29212 and Pseudomonas aeruginosa ATCC
27853 were used as controls for MIC determination on
each plate. Bacteria were incubated in the testing medium
with various antimicrobials and concentrations at 37°C for
16-18 hr. The percentage of isolates showing resistance to
each antimicrobial agent was determined by measuring the
MIC and comparing it to the resistance breakpoint established by CLSI(25). For the MIC breakpoint values which
were not provided by CLSI, the resistance breakpoints for
bovine respiratory disease pathogens were used(25). These
included ceftiofur (susceptible: ≤ 2 mg/L; resistant: ≥ 8
mg/L) and florfenicol (susceptible: ≤ 2 mg/L; resistant: ≥
8 mg/L). According to the MIC breakpoints of the BSAC
(British Society for Antimicrobial Chemotherapy) for
Acinetobacter spp. and Enterobacteriaceae, resistance to
colistin was defined as MIC > 4 mg/L(26).
III. Detection of Florfenicol and Chloramphenicol Resistance Genes
Chromosomal DNA was prepared using a Wizard
genomic DNA purification kit (Promega, Madison, WI,
USA). The chloramphenicol resistance genes (cat-1, cat2, and cat-3) and efflux pump genes ( floR and cmlA) were
amplified by polymerase chain reaction (PCR). The primers used are listed in Table 1 and PCR was performed as
previously described (21,22). The PCR was performed on a
GeneAmp PCR System 9700 (Applied Biosystems, Inc.,
Foster City, CA, USA). The PCR products were purified
using a PCR purification kit (Qiagen, Valencia, CA, USA)
and confirmed by nucleotide sequencing.
IV. The Effects of PAβN on the Active Efflux Systems
In order to investigate the inhibitory ability of
PAβN (Sigma) on bacterial multiple component efflux
systems, 44 isolates were selected at random from each
resistance genotype. These included four cmlA-carrying
isolates, twelve floR-carrying isolates, twelve floR- and
cmlA-carrying isolates, three cmlA-, floR-, and cat-1carrying isolates, two cmlA- and cat-1-carrying isolates,
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Table 1. Primers used in this study
Target genes

Sequence (5’-3’)

cat-1-F

AGTTGCTCAATGTACCTATAACC

cat-1-R

TTGTAATTCATTAAGCATTCTGCC

cat-2-F

ACACTTTGCCCTTTATCGTC

cat-2-R

TGAAAGCCATCACATACTGC

cat-3-F

TTCGCCGTGAGCATTTTG

cat-3-R

TCGGATGAGTATGGGCAAC

floR-F

CGCCGTCATTCCTCACCTTC

florR-R

GATCACGGGCCACGCTGTGTC

cmlA-F

CCGCCACGGTGTTGTTGTTATC

cmlA-R

CACCTTGCCTGCCCATCATTAG

Annealing temp (°C)

Products size (bp)

50

547

50

543

50

286

50

215

40

698

References
22

22

22

22

21

Table 2. Antimicrobial susceptibility profiles and percentage of resistance of 351 pig florfenicol-resistant E. coli strains
Antimicrobial agents (mg/L)

S

b

Rb

MIC90

R%

16/8

128/64

37.8

≤ 8/4

≥ 32/16

> 1024

> 1024

93.9

≤8

≥ 32

Ceftiofur

1

16

26.3

≤2

≥8

Colistin

2

8

45.9

–

>4

Gentamicin

64

> 1024

61.0

≤4

≥ 16

Oxytetracycline

> 1024

> 1024

99.4

≤4

≥ 16

Nalidixic acid

> 1024

> 1024

96.2

≤8

≥ 32

Ciprofloxacin

2

128

55.2

≤1

≥4

Enrofloxacin

8

256

61.7

≤ 0.5

≥2

Florfenicol

512

> 1024

100

≤2

≥8

Chloramphenicol

512

1024

100

≤8

≥ 32

Ampicillin

b

a

MIC50

Amoxicillin-clavulanic acid

a

Breakpoint

Florfenicol-resistant E. coli strains (n = 351)

R%: percentage of resistance
S: susceptibility, R: resistant.

eight floR- and cat-1-carrying isolates, and three floRand cat-2-carrying isolates. The MICs of florfenicol and
chloramphenicol were determined in the presence or
absence of PAβN at 80 mg/L (27). The reference strain E.
coli ATCC25922 was used as a control. A 4-fold or 8-fold
reduction in the MIC value after the addition of PAβN
was considered as a positive effect (23).
V. Statistical Analysis
The statistical tests used were the chi-square test
and Fisher’s exact test, using the Mixed Procedure in
SAS (version 8.2; SAS Institute, Inc., Cary, NC, USA).

The correlations between MICs of florfenicol/chloramphenicol and resistance genes ( floR and cmlA) were
performed using the Pearson correlation coefficient. For
all comparisons, a value of p < 0.05 was considered to be
of statistically significant difference.

RESULTS
I. Florfenicol-Resistant E. coli Strains and Antimicrobial
Susceptibility Testing
A total of 351 florfenicol-resistant E. coli strains
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Table 3. Prevalence of cmlA, floR, cat-1, and cat-2 genes in florfenicol-resistant E. coli isolates
Group

Resistance genotype
b

No. of isolates positive for
resistance gene/No. tested (%)

MIC (mg/L)a
Florfenicol

Chloramphenicol

1

cmlA only

29/351 (8.3)

8-512

32-512

2

floR onlyb

69/351 (19.7)

32- > 1024

32- > 1024

173/351 (49.3)

32- > 1024

32- > 1024

11/351 (3.1)

32-1024

256- > 1024

c

3

cmlA + floR

4

cmlA + floR+ cat-1

5

cmlA + cat-1

2/351 (0.6)

16-256

128-256

6

floR + cat-1

25/351 (7.1)

32- >1024

256-1024

7

floR + cat-2

13/351 (3.7)

32-512

256- > 1024

29/351 (8.3)

16-512

32-1024

8

N.I.

d

a

Determined by agar-dilution methods according to CLSI standards and guidelines.
Statistically significant differences (p < 0.001) between cmlA only (Group 1) and floR only (Group 2).
c
Statistically significant differences (p < 0.001) between cmlA & floR (Group 3) and cmlA only (Group 1) and floR only (Group 2).
d
Not identified: the isolates showed florfenicol resistance but didn’t carry any of these four genes.
b

were isolated from 600 samples from porcine rectal
swabs of nursery pigs (61.5%; 123/200), grower-finisher pigs (62.5%; 125/200), and sows (51.5%; 103/200)
between 2003 and 2007. For the florfenicol-resistant
E. coli isolates (n = 351), the MIC of chloramphenicol
ranged from 32 to > 1024 mg/L and the MIC of florfenicol
ranged from 8 to > 1024 mg/L. Our results also showed
that most isolates (70.4%; 247/351) had high level of resistance to both phenicols (MICs 512- > 1024 mg/L; Table
2). The annual percentage of florfenicol-resistant E. coli
increased continuously throughout the sampling period
(2003-2007), from 39.2% (47/120) to 45.8% (55/120), 60%
(72/120), 69.2% (83/120), and 78.3% (94/120), respectively. The MICs at which 50% and 90% of the isolates
were inhibited (MIC50 and MIC90) and the antimicrobial
susceptibility profiles against the different antimicrobial agents are summarized in Table 2. The resistance of
florfenicol-resistant E. coli strains to chloramphenicol,
oxytetracycline, nalidixic acid, ampicillin, enrofloxacin,
gentamicin, and ciprofloxacin was 100%, 99.4%, 96.2%,
93.9%, 61.7%, 61.0%, and 55.2%, respectively. These
isolates also showed a moderate level of resistance to
colistin (45.9%), amoxicillin-clavulanic acid (37.8%), and
ceftiofur (26.3%).
II. Detection of Florfenicol and Chloramphenicol Resistance Genes
The total DNA of the 351 florfenicol-resistant E.
coli isolates was extracted as the DNA template for PCR
detection of floR, cmlA, cat-1, cat-2, and cat-3 genes.
These results are presented in Table 3. A total of 291
floR-positive E. coli strains were detected from nursery pigs (72.4%; 89/123), grower-finisher pigs (92.8%;
116/125), and sows (83.5%; 86/103). The frequency of

Table 4. Correlations between minimum inhibitory concentration
(MIC) of florfenicol/chloramphenicol and resistance genes
Antibiotic

floR

cmlA

r

p value

r

p value

Florfenicol

0.8643

0.002

-0.2961

0.4392

Chloramphenicol

0.7845

0.036

0.7969

0.032

detection of the floR (or cat-1) gene was greater than that
of the cmlA (or cat-2) gene. Our results also showed that
184 E. coli isolates (52.4%) were carrying both the floR
and cmlA genes. However, the cat-1 and cat-2 genes did
not exist concurrently in any of the tested isolates. No
cat-3 gene was detected in any of the isolates screened.
Within the sampling period, the annual percentage of
the floR resistance gene increased over time. In the years
2003 thru 2007, the annual percentage of floR-positive
E. coli isolates was 33%, 38%, 48%, 55.8%, and 69.2%,
respectively. The percentage of florfenicol-resistance E.
coli isolates between 2003 and 2007 with the cmlA gene
was 23.3%, 24.2%, 30.8%, 48.3%, and 52.5%, respectively. However, the percentage of the cat-1 and cat-2
genes decreased over time. Between 2003 and 2007, the
percentage of florfenicol-resistance E. coli isolates with
the cat-1(cat-2) gene was 9.2% (6.7%), 7.5% (1.7%), 5.8%
(0.8%), 5.8% (1.7%), and 3.3% (0%), respectively. The
Pearson correlation test indicated that florfenicol/chloramphenicol resistance was correlated with the floR gene
(r = 0.78 - 0.86; p < 0.05). However, the chloramphenicol
efflux gene (cmlA) did not confer resistance to florfenicol
(r = -0.2961; p = 0.4392; Table 4).
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III. The Effects of PAβN on the Active Efflux Systems
The MIC values of florfenicol in the absence and in
the presence of the efflux inhibitor PAβN are listed in
Table 5. Forty-four randomly preselected isolates and E.
coli ATCC 25922 could be subdivided into seven groups.
Group 1 and group 5 isolates carried the cmlA gene
plus PAβN in the medium, with only a 2-fold decrease
in the MIC of florfenicol but a 4- to 8-fold decrease in
the MIC of chloramphenicol. Group 2, group 6, and
group 7 isolates carried the floR gene, with a 4- to 32fold decrease in the MIC of florfenicol and a 4- to 8-fold
decrease in the MIC of chloramphenicol. Group 3 and
group 4 isolates carried floR and cmlA genes, with a 4- to
64-fold decrease in the MIC of florfenicol and a 4- to 16fold decrease in the MIC of chloramphenicol. Group 4,
group 5, group 6, and group 7 isolates also carried cat-1
or cat-2. However, these two cat genes did not have any
significant effect on the MICs of the two phenicols.

DISCUSSIONS
In Taiwan, chloramphenicol has not been used for
any purpose in food-producing animals since 2002. After
chloramphenicol was banned, florfenicol was used to
replace chloramphenicol in clinical therapy. The annual

percentage of resistance to florfenicol in the isolated E.
coli strains doubled from 39.2% in 2003 to 78.3% in 2007.
This elevation of resistance is correlated with the parallel
increase in the annual percentage of isolates carrying the
floR gene (from 33% to 69.2%; Table 4). This is the most
important reason to explain the increase of florfenicol
resistance over time. Additionally, the florfenicol-resistant isolates contained the cmlA gene and chloramphenicol resistance in our samples was unexpectedly high. Our
susceptibility data have demonstrated the persistence of
florfenicol resistance in porcine E. coli in combination
with a high percentage of resistance to chloramphenicol
(Table 2). Previous studies have shown that the continuous use of florfenicol could have increased the selective
pressure for both florfenicol and chloramphenicol resistance (6,15,17) and the existence of floR could contribute to
enhance the ability to efflux chloramphenicol(15,17-20).
According to the farm medical records, no farm
has used florfenicol in the grower-finisher pigs and sows
prior to sampling. However, the higher percentage of floR
observed in these pigs may be due to the dissemination
of floR via high molecular weight plasmids and/or other
mobile genetic elements (transposons, integrons)(6,17).
The location of the resistance gene on a mobile element
is an important prerequisite for fast and efficient distribution among bacteria of the same or different genera and
species, as well as for the resistant genes transfer between

Table 5. MICs determined in the absence or presence of PAβN and the two phenicol resistance genes detected in the E. coli isolates
Strains

florfenicol

F+Ia

Relative fold

chloramphenicol

C+Ib

Relative fold

93-14

16

8

2

128

16

8

93-89

32

16

2

64

8

8

96-78

512

256

2

128

32

4

96-109

512

256

2

512

64

8

92-91

1024

256

4

1024

256

4

92-111

32

4

8

256

32

8

93-26

256

32

8

1024

256

4

93-27

32

2

16

512

64

8

93-62

32

8

4

32

8

4

94-28

512

32

16

512

128

4

94-30

512

128

4

512

128

4

94-2367

512

128

4

256

64

4

95-32

1024

256

4

1024

256

4

95-93

512

128

4

1024

256

4

96-73

512

128

4

32

8

4

Group 1 cmlA only

Group 2 floR only
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Table 5. Continued.
Strains

florfenicol

F+Ia

Relative fold

chloramphenicol

C+Ib

Relative fold

1024

128

8

1024

256

4

92-23

512

128

4

512

32

16

92-36

32

0.5

64

128

16

8

93-129

512

128

4

1024

128

8

93-2389

512

64

8

1024

256

4

94-36

256

32

8

512

32

16

94-52

512

64

8

32

8

4

95-37

256

32

8

64

8

4

95-50

512

128

4

512

128

4

95-128

512

64

8

1024

64

16

96-65

32

2

16

16

4

4

96-131

> 1024

64

> 16

> 1024

256

>4

96-165

512

128

4

32

8

4

95-77

32

4

8

256

32

8

95-133

32

4

8

1024

128

8

96-118

32

2

16

1024

256

4

16

8

2

128

32

4

32

16

2

256

32

8

> 1024

256

>4

1024

128

8

93-116

256

32

8

512

128

4

94-14

32

1

32

512

128

4

94-44

> 1024

256

>4

1024

256

4

94-123

1024

256

4

512

128

4

95-31

512

64

8

512

128

4

95-42

> 1024

256

>4

1024

128

8

96-58

32

2

16

256

64

4

92-121

512

64

8

1024

256

4

93-55

512

64

8

> 1024

256

>4

95-142

32

4

8

256

64

4

1

1

-

4

4

-

96-94
Group 3 cmlA + floR

Group 4 cmlA + floR + cat-1c

Group 5 cmlA + cat-1 c
93-34
94-49
Group 6 floR + cat-1

c

92-42

Group 7 floR + cat-2 c

Reference strain
E. coli ATCC 25922
a

F+I: florfenicol+PAβN
CHL+I: chloramphenicol+PAβN
c
The isolates carried the cat-1 or cat-2 gene which showed no significant effect on the MICs of the two phenicols.
b
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human and animal bacteria (6). The mechanism of resistance in these isolates is the subject of further study.
In the present study, the number of floR-carrying
isolates (291/351; p < 0.001) was more than the number of
cmlA-carrying isolates (215/351) and the number of cat-1
or cat-2 carrying isolates (51/351; Table 3). Most of the
isolates (184/351) carried both cmlA and floR (group 3:
173 strains and group 4: 11 strains) and only 29 carried
the single cmlA gene (group 1). After analyzing the
distribution of group 1 isolates, it was found that most of
them were collected in the first and second years (data not
shown). Interestingly, 60 isolates with florfenicol MICs >
8 mg/L were negative for the floR gene (group 1, group
5, and group 8; Table 3). The results of Southern bolt
hybridization also indicated that no plasmid or chromosomal resistance determinants ( floR gene) were found for
these isolates. Whether some nonspecific mechanisms,
such as overproduction of the AcrAB-TolC multidrug
efflux system, were responsible for the elevated MICs
for florfenicol among these floR-negative E. coli isolates
remains unknown(2).
After comparing the florfenicol and chloramphenicol MIC values as shown in Table 3, we arrived at the
following conclusions. First, group 2 ( floR only) had
higher florfenicol and chloramphenicol MIC values than
group 1 (cmlA only). Second, the isolates containing floR
and cmlA genes (group 3) or only the floR gene (group 2)
had no significant difference on the MIC values. Third,
the chloramphenicol acetyltransferases (cat-1 and cat-2)
were not the predominant contributors for chloramphenicol resistance, which is consistent with previous studies (20). There was no additive effect on MIC values (Table
3) by two different resistance mechanisms, i.e., floR
and cat genes (Group 6 and 7). Fourth, the MIC values
increased significantly as long as the isolates were carrying floR since FloR can efflux both florfenicol and chloramphenicol out of the bacterial cell.
Active extrusion of florfenicol via efflux pumps is
an important mechanism for the resistance of gram-negative bacteria. In this study, the MICs for both florfenicol
and chloramphenicol of 44 randomly selected isolates
are shown in Table 5. The effects of PAβN on the active
efflux systems were tested. On the basis of fold decrease
of florfenicol resistance in the presence of PAβN in each
group, our data indicated that group 2 (only floR gene),
group 3 ( floR and cmlA genes), group 4 ( floR, cmlA, and
cat-1 genes), group 6 ( floR and cat-1 genes), and group
7 isolates ( floR and cat-2 genes) showed a 4- to 64-fold
decrease in the florfenicol MIC levels. Group 1 (only
cmlA) and group 5 (cmlA and cat-1 genes) had little or
no change in the MIC values for florfenicol. Once again,
these results confirm the floR was the predominant
contributor for the florfenicol resistance.
In summary, we describe the prevalence of resistance of E. coli to florfenicol and chloramphenicol and
their relationship to floR or cmlA gene. When a stronger
efflux system was present, the cat genes showed much

less or no effect on the MICs of the two phenicols. When
PAβN was present, the floR gene was inhibited and the
MICs were altered accordingly. More detailed studies
are required to focus on the importance of these genetic
relationships and to rationalize the use of antimicrobial
agents in both humans and other animals.
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